Guest: William A. Kilgo, MD
According to new research featured at the joint ECTRIMS-ACTRIMS meeting, the Multiple Sclerosis Disease Activity (MSDA) Test is a reliable indicator of recent objective disease activity when used within an academic clinic. Based on these findings, Dr. Andrew Wilner sits down with lead author of the study, Dr. William Kilgo, to discuss how the MSDA can be applied in our real-world clinical practice.